▶ 調査レポート

世界のパクリタキセル薬剤溶出バルーン市場2023年:企業・地域・種類・用途別分析

• 英文タイトル:Global Paclitaxel Drug-Eluting Balloon Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のパクリタキセル薬剤溶出バルーン市場2023年:企業・地域・種類・用途別分析 / Global Paclitaxel Drug-Eluting Balloon Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 / MRC309Z7445資料のイメージです。• レポートコード:MRC309Z7445
• 出版社/出版日:GlobalInfoResearch / 2023年9月
• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(2-3営業日)
• 産業分類:医療機器&消耗品
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
GlobalInfoResearchの最新の調査によると、世界のパクリタキセル薬剤溶出バルーンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のパクリタキセル薬剤溶出バルーン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- パクリタキセル薬剤溶出バルーンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

パクリタキセル薬剤溶出バルーン市場は種類と用途によって区分されます。2018年~2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・バルーン・オンリーコーティング、薬剤コーティングバルーン

用途別セグメント
・末梢動脈疾患、冠動脈疾患

主要な市場プレーヤー
・Medtronic、Boston Scientific、B. Braun、Cook Medical、Cardionovum、Aachen Resonance、QT Vascular、Biotronic、Philips、Eurocor、Yinyi Biotech、Lepu Medical Technology

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、パクリタキセル薬剤溶出バルーン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なパクリタキセル薬剤溶出バルーンメーカーの企業概要、2019年~2022年までのパクリタキセル薬剤溶出バルーンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なパクリタキセル薬剤溶出バルーンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別パクリタキセル薬剤溶出バルーンの販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までのパクリタキセル薬剤溶出バルーンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域でのパクリタキセル薬剤溶出バルーン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびパクリタキセル薬剤溶出バルーンの産業チェーンを掲載しています。
・第14、15章では、パクリタキセル薬剤溶出バルーンの販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
- パクリタキセル薬剤溶出バルーンの概要
- 種類別分析(2018年vs2022年vs2029年):バルーン・オンリーコーティング、薬剤コーティングバルーン
- 用途別分析(2018年vs2022年vs2029年):末梢動脈疾患、冠動脈疾患
- 世界のパクリタキセル薬剤溶出バルーン市場規模・予測
- 世界のパクリタキセル薬剤溶出バルーン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Medtronic、Boston Scientific、B. Braun、Cook Medical、Cardionovum、Aachen Resonance、QT Vascular、Biotronic、Philips、Eurocor、Yinyi Biotech、Lepu Medical Technology
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年:バルーン・オンリーコーティング、薬剤コーティングバルーン
・用途別分析2018年-2029年:末梢動脈疾患、冠動脈疾患
・パクリタキセル薬剤溶出バルーンの北米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・パクリタキセル薬剤溶出バルーンのヨーロッパ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・パクリタキセル薬剤溶出バルーンのアジア市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・パクリタキセル薬剤溶出バルーンの南米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・パクリタキセル薬剤溶出バルーンの中東・アフリカ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

According to our (Global Info Research) latest study, the global Paclitaxel Drug-Eluting Balloon market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Paclitaxel drug-eluting balloons are a type of medical device used in the treatment of peripheral artery disease (PAD). They are designed to deliver the drug paclitaxel to the affected area and reduce the risk of restenosis (re-narrowing of the artery).
This report is a detailed and comprehensive analysis for global Paclitaxel Drug-Eluting Balloon market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Paclitaxel Drug-Eluting Balloon market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Paclitaxel Drug-Eluting Balloon market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Paclitaxel Drug-Eluting Balloon market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Paclitaxel Drug-Eluting Balloon market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Paclitaxel Drug-Eluting Balloon
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Paclitaxel Drug-Eluting Balloon market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, B. Braun, Cook Medical and Cardionovum, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Paclitaxel Drug-Eluting Balloon market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Balloon-Only Coating
Drug-Coated Balloon
Market segment by Application
Peripheral Artery Disease
Coronary Artery Disease
Major players covered
Medtronic
Boston Scientific
B. Braun
Cook Medical
Cardionovum
Aachen Resonance
QT Vascular
Biotronic
Philips
Eurocor
Yinyi Biotech
Lepu Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Paclitaxel Drug-Eluting Balloon product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Paclitaxel Drug-Eluting Balloon, with price, sales, revenue and global market share of Paclitaxel Drug-Eluting Balloon from 2018 to 2023.
Chapter 3, the Paclitaxel Drug-Eluting Balloon competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Paclitaxel Drug-Eluting Balloon breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Paclitaxel Drug-Eluting Balloon market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Paclitaxel Drug-Eluting Balloon.
Chapter 14 and 15, to describe Paclitaxel Drug-Eluting Balloon sales channel, distributors, customers, research findings and conclusion.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Paclitaxel Drug-Eluting Balloon
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Paclitaxel Drug-Eluting Balloon Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Balloon-Only Coating
1.3.3 Drug-Coated Balloon
1.4 Market Analysis by Application
1.4.1 Overview: Global Paclitaxel Drug-Eluting Balloon Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Peripheral Artery Disease
1.4.3 Coronary Artery Disease
1.5 Global Paclitaxel Drug-Eluting Balloon Market Size & Forecast
1.5.1 Global Paclitaxel Drug-Eluting Balloon Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Paclitaxel Drug-Eluting Balloon Sales Quantity (2018-2029)
1.5.3 Global Paclitaxel Drug-Eluting Balloon Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Paclitaxel Drug-Eluting Balloon Product and Services
2.1.4 Medtronic Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Medtronic Recent Developments/Updates
2.2 Boston Scientific
2.2.1 Boston Scientific Details
2.2.2 Boston Scientific Major Business
2.2.3 Boston Scientific Paclitaxel Drug-Eluting Balloon Product and Services
2.2.4 Boston Scientific Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boston Scientific Recent Developments/Updates
2.3 B. Braun
2.3.1 B. Braun Details
2.3.2 B. Braun Major Business
2.3.3 B. Braun Paclitaxel Drug-Eluting Balloon Product and Services
2.3.4 B. Braun Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 B. Braun Recent Developments/Updates
2.4 Cook Medical
2.4.1 Cook Medical Details
2.4.2 Cook Medical Major Business
2.4.3 Cook Medical Paclitaxel Drug-Eluting Balloon Product and Services
2.4.4 Cook Medical Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cook Medical Recent Developments/Updates
2.5 Cardionovum
2.5.1 Cardionovum Details
2.5.2 Cardionovum Major Business
2.5.3 Cardionovum Paclitaxel Drug-Eluting Balloon Product and Services
2.5.4 Cardionovum Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Cardionovum Recent Developments/Updates
2.6 Aachen Resonance
2.6.1 Aachen Resonance Details
2.6.2 Aachen Resonance Major Business
2.6.3 Aachen Resonance Paclitaxel Drug-Eluting Balloon Product and Services
2.6.4 Aachen Resonance Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Aachen Resonance Recent Developments/Updates
2.7 QT Vascular
2.7.1 QT Vascular Details
2.7.2 QT Vascular Major Business
2.7.3 QT Vascular Paclitaxel Drug-Eluting Balloon Product and Services
2.7.4 QT Vascular Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 QT Vascular Recent Developments/Updates
2.8 Biotronic
2.8.1 Biotronic Details
2.8.2 Biotronic Major Business
2.8.3 Biotronic Paclitaxel Drug-Eluting Balloon Product and Services
2.8.4 Biotronic Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Biotronic Recent Developments/Updates
2.9 Philips
2.9.1 Philips Details
2.9.2 Philips Major Business
2.9.3 Philips Paclitaxel Drug-Eluting Balloon Product and Services
2.9.4 Philips Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Philips Recent Developments/Updates
2.10 Eurocor
2.10.1 Eurocor Details
2.10.2 Eurocor Major Business
2.10.3 Eurocor Paclitaxel Drug-Eluting Balloon Product and Services
2.10.4 Eurocor Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eurocor Recent Developments/Updates
2.11 Yinyi Biotech
2.11.1 Yinyi Biotech Details
2.11.2 Yinyi Biotech Major Business
2.11.3 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Product and Services
2.11.4 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Yinyi Biotech Recent Developments/Updates
2.12 Lepu Medical Technology
2.12.1 Lepu Medical Technology Details
2.12.2 Lepu Medical Technology Major Business
2.12.3 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Product and Services
2.12.4 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Lepu Medical Technology Recent Developments/Updates
3 Competitive Environment: Paclitaxel Drug-Eluting Balloon by Manufacturer
3.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Manufacturer (2018-2023)
3.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Manufacturer (2018-2023)
3.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Paclitaxel Drug-Eluting Balloon by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Paclitaxel Drug-Eluting Balloon Manufacturer Market Share in 2022
3.4.2 Top 6 Paclitaxel Drug-Eluting Balloon Manufacturer Market Share in 2022
3.5 Paclitaxel Drug-Eluting Balloon Market: Overall Company Footprint Analysis
3.5.1 Paclitaxel Drug-Eluting Balloon Market: Region Footprint
3.5.2 Paclitaxel Drug-Eluting Balloon Market: Company Product Type Footprint
3.5.3 Paclitaxel Drug-Eluting Balloon Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Paclitaxel Drug-Eluting Balloon Market Size by Region
4.1.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Region (2018-2029)
4.1.2 Global Paclitaxel Drug-Eluting Balloon Consumption Value by Region (2018-2029)
4.1.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Region (2018-2029)
4.2 North America Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)
4.3 Europe Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)
4.4 Asia-Pacific Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)
4.5 South America Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)
4.6 Middle East and Africa Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
5.2 Global Paclitaxel Drug-Eluting Balloon Consumption Value by Type (2018-2029)
5.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
6.2 Global Paclitaxel Drug-Eluting Balloon Consumption Value by Application (2018-2029)
6.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Application (2018-2029)
7 North America
7.1 North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
7.2 North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
7.3 North America Paclitaxel Drug-Eluting Balloon Market Size by Country
7.3.1 North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2029)
7.3.2 North America Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
8.2 Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
8.3 Europe Paclitaxel Drug-Eluting Balloon Market Size by Country
8.3.1 Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2029)
8.3.2 Europe Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Paclitaxel Drug-Eluting Balloon Market Size by Region
9.3.1 Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Paclitaxel Drug-Eluting Balloon Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
10.2 South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
10.3 South America Paclitaxel Drug-Eluting Balloon Market Size by Country
10.3.1 South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2029)
10.3.2 South America Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Paclitaxel Drug-Eluting Balloon Market Size by Country
11.3.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Paclitaxel Drug-Eluting Balloon Market Drivers
12.2 Paclitaxel Drug-Eluting Balloon Market Restraints
12.3 Paclitaxel Drug-Eluting Balloon Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Paclitaxel Drug-Eluting Balloon and Key Manufacturers
13.2 Manufacturing Costs Percentage of Paclitaxel Drug-Eluting Balloon
13.3 Paclitaxel Drug-Eluting Balloon Production Process
13.4 Paclitaxel Drug-Eluting Balloon Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Paclitaxel Drug-Eluting Balloon Typical Distributors
14.3 Paclitaxel Drug-Eluting Balloon Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer